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Opportunistic infections with the saprophytic yeast Candida albicans are a major
cause of morbidity in immunocompromised patients. While the interaction of cells
and molecules of innate immunity with C. albicans has been studied to great depth,
comparatively little is known about the modulation of adaptive immunity by C. albicans.
In particular, direct interaction of proteins secreted by C. albicans with CD4+ T cells
has not been studied in detail. In a first screening approach, we identified the pH-
regulated antigen 1 (Pra1) as a molecule capable of directly binding to mouse CD4+
T cells in vitro. Binding of Pra1 to the T cell surface was enhanced by extracellular Zn2+
ions which Pra1 is known to scavenge from the host in order to supply the fungus
with Zn2+. In vitro stimulation assays using highly purified mouse CD4+ T cells showed
that Pra1 increased proliferation of CD4+ T cells in the presence of plate-bound anti-
CD3 monoclonal antibody. In contrast, secretion of effector cytokines such as IFNγ
and TNF by CD4+ T cells upon anti-CD3/ anti-CD28 mAb as well as cognate antigen
stimulation was reduced in the presence of Pra1. By secreting Pra1 C. albicans, thus,
directly modulates and partially controls CD4+ T cell responses as shown in our in vitro
assays.
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INTRODUCTION
Candida albicans is a commensal on human skin and mucosal surfaces. In situations of
immunosuppression, C. albicans may, however, become pathogenic. Prominent examples of
C. albicans-induced pathologies are mucosal or skin candidiasis as well as C. albicans septicemia in
ICU and/ or HIV/Aids patients (Klein et al., 1984; Sangeorzan et al., 1994; Leroy et al., 2009). In
the latter cohorts, loss of CD4+ T cells is the hallmark of immunodeficiency. This highlights the
importance of CD4+ T cells for controlling C. albicans infections in humans.
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To allow commensalism, C. albicans has evolved a number
of evasion strategies to protect itself from attack by the host’s
immune system (Zipfel et al., 2011). Immune evasion might
be beneficial during commensal growth as it avoids potentially
harmful inflammation and adaptive immune responses. The very
same mechanisms might, however, contribute to C. albicans
pathogenicity once epithelial barriers are disturbed. Research
into the factors driving C. albicans pathogenicity led to the
discovery of the pH-regulated antigen 1 (Pra1) as a multifaceted
immune evasion protein (Zipfel et al., 2011). Pra1 interferes
with innate immunity including the complement cascade on
different levels thereby efficiently protecting the fungus from
complement attack. Moreover, Pra1 scavenges zinc from the host,
thus, ensuring sufficient supply of the fungus with this bivalent
cation (Citiulo et al., 2012). For both functions, complement
inhibition and zinc scavenging, Pra1 is first secreted, interacts
with complement proteins or zinc in solution and then the
complex of Pra1 and its binding partner are recruited back to the
C. albicans surface (Zipfel et al., 2011; Citiulo et al., 2012).
As Pra1 is secreted by C. albicans we hypothesized that this
fungal protein might also be capable of bypassing fungal sensing
by DCs (Romani, 2011) and of directly interacting with CD4+
T cells, thus, modulating T cell function in its favor. Having
established that recombinantly expressed Pra1 binds to mouse
CD4+ T cells, we, thus, analyzed the impact of Pra1 on T cell
activation, expansion and effector cytokine secretion. Our data
suggest that C. albicans directly modulates anti-fungal immunity
through secreting T cell-binding proteins like Pra1.
MATERIALS AND METHODS
Mice
Wild-type C57BL/6J mice and OT-II C57BL/6J mice (Barnden
et al., 1998) were bred in the animal facility of the Institute
for Virology and Immunobiology, University of Würzburg.
CD55−/− C57BL/6 mice (Sun et al., 1999) were obtained from
the University of Cardiff and also bred in our animal facility.
Crry−/− C57BL/6 (Ruseva et al., 2009) and CD59a−/− C57BL/6
mice (Holt et al., 2001) were bred at Cardiff University. All mice
were kept in a specified pathogen free conventionally housed
environment and used for experiments between six and 21 weeks
of age.
Antibodies and Flow Cytometry
The following antibodies and reagents were used to stain mouse
cells: anti-CD4 Alexa Fluor 647 (clone RM4-5), anti-IFNγ Alexa
Fluor 488 (clone XMG1.2), Streptavidin-PerCP (all BioLegend,
San Diego, CA, USA), anti-CD25 biotin (clone 7D4, BD
Pharmingen, Franklin Lakes, NJ, USA) anti-CD55 unconjugated
(RIKO-3, Biolegend), anti-CD11b FITC (clone M1/70), anti-
B220 Alexa Fluor 647 (clone RA3-6B2) (all BD Pharmingen),
anti-CD3 PerCp (clone 145-2C11, BioLegend).
For staining of Pra1 a polyclonal antibody was raised in
rabbits by immunization with purified recombinant Pra1. Aspf2-
antiserum was generated by immunization of mice with purified
recombinant Aspf2. Secondary polyclonal antibodies for staining
of primary antibodies were goat anti-mouse-Ig FITC and donkey
anti-rabbit-Ig PE (Jackson Immunoresearch, West Grove, PA,
USA). Flow cytometry was performed on a FACSCalibur or LSR
II flow cytometer using either CellQuest or DIVA software (BD
Bioscience, Franklin Lakes, NJ, USA). We used FlowJo (TreeStar)
to further analyze FACS data.
Protein Expression and Purification
Recombinant Pra1wt and Aspf2 were expressed in Pichia
pastoris and isolated via the His-tag (Luo et al., 2009;
Bacher et al., 2014). For protein overexpression and
purification, the pra1 gene encoding a protein lacking the
C-terminal 61-amino acid was amplified from the pPICZαB-
Pra1wt clone using the sequence specific forward primers
ACTGAATTCTGTGGAGCCATCCGCAGTTTGAAAAAAGCG
CGGCACCAGTTACGGTTACC and reverse primer ACTGGT
ACCGCGCACCCTTCGCCGGGAATTG, containing the res-
triction sites EcoRI and KpnI. The PCR product and plasmid
pPICZαB were enzymatically digested, ligated, and sub-cloned
into pPICZαB (Invitrogen, Karlsruhe, Germany). The resulting
plasmid pPICZαB-Pra11C61 was transfected and overexpressed
in Pichia pastoris X33 (EasySelectTMPichia Expression Kit,
Invitrogen, Karlsruhe, Germany). The Pra11C61 was purified as
described (Luo et al., 2009).
Organ Processing and FACS Stainings
Single cell suspensions were generated by mashing cervical,
axillary, inguinal and mesenteric lymph nodes or spleens
through a cell strainer (Falcon, Pittsburg, PA, USA). Single cell
suspensions of splenocytes were then subjected to red cell lysis by
hypoosmotic shock. Lymph node and red cell-lysed spleen cells
were then resuspended in buffered salt solution (BSS) containing
0.1% (w/v) bovine serum albumin (BSA). Total lymph node or
spleen cells were incubated with Pra1 (10 µg/ ml) or Aspf2
(10 µg/ ml) in PBS at 37◦C for 30 or 45 min. For investigation of
the influence of zinc on Pra1 binding, ZnCl2 (1, 10, or 100 µM)
was added while incubating cells together with Pra1. After
washing bound Pra1 or Aspf2 were detected with a polyclonal
anti-Pra1- (rabbit) or anti-Aspf2- (mouse) antiserum followed
by PE anti-rabbit Ig polyclonal antibody (donkey; Dianova) or
FITC anti-rabbit Ig polyclonal antibody (donkey; Dianova). For
further stainings the samples were blocked with normal rabbit
serum (1:500) or normal mouse Ig (20 µg/ ml, Sigma) followed
by incubation with anti-CD4 mAb (Alexa Fluor 647) alone or
together with anti-CD3 mAb (PerCp). For Kv1.3 detection, ShK-
F6CA (0.3 µg/ml; Bachem AG, Bubendorf, Switzerland) was
incubated together with mAb against cell surface proteins for
30 min at room temperature (Beeton et al., 2003).
Polyclonal Stimulations In Vitro
To test for co-stimulation lymph node cells from WT mice were
first enriched for CD4+ T cells (MagniSort Mouse CD4 T cell
Enrichment Kit, eBioscience, Santa Clara, CA, USA or CD4+ T
cell isolation kit, Miltenyi) resulting in at least 93% pure CD4+
T cells. Afterwards the cells were stained with anti-CD4-Alexa
Fluor 647 and CD4+ T cells sorted using the FACS Aria III (BD)
cell sorter (100% purity). For analysis of cell proliferation cells
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were incubated for 5 min at RT with 5 µM Vybrant CFDA SE Cell
Tracer Kit (CFSE, Life Technologies, Carlsbad, CA, USA). Anti-
CD3-mAb (2.5 µg/ ml, clone 145-2C11, BioLegend) was bound
to 96-flat bottom-plates (Greiner, Kremsmuenster, Austria) after
incubation on the plate o/n at 4◦C dissolved in 0.1 M NaHCO3-
buffer (pH 9). After coating of the plate, non-specific binding
was blocked by incubation with normal mouse immunoglobulin
(20 µg/ml in BSS/0.1% BSA (w/v), Sigma Aldrich, St. Louis, MO,
USA) at 37◦C for 30 min. 1 × 105 CFSE-labeled CD4+ T cells
were added per well and anit-CD28 mAb E18 (Exbio) (Dennehy
et al., 2006) (1 and 10 µg/ ml) or Pra1 (0.1 pg/ ml – 100 ng/ ml)
were added in solution. For the cultures, we used complete RPMI
1640 medium supplemented with 1 mM sodium pyruvate, non-
essential amino acids MEM (0.05–2 mM), 100 U/ ml penicillin
and 100 µg/ml streptomycin, 30 µM mercaptoethanol, 2 mM
L-glutamine (all Gibco) and 10% (v/v) heat-inactivated fetal calf
serum. After 3 days, CD4 and CD25 were stained and expression
of both markers, together with CFSE dilution, was analyzed by
flow cytometry. To determine cytokine secretion, magnetically
purified CD4+ T cells were cultured with plate-bound anti-CD3
mAb in the presence of soluble Pra1 (1–100 ng/ml) or anti-CD28
mAb (10 µg/ml) as already described. Alternatively, we coated
Dynabeads R© Pan Mouse IgG (Invitrogen) with 10 µg/ml anti-
CD3 mAb (clone 145-2C11, BioLegend) and 1 µg/ml anti-CD28
mAb (clone E18) according to the manufacturer’s instructions
and added the beads at a bead to cell ratio of 5:1 to the cultures.
After three days, culture supernatants were harvested and frozen
at –70◦ C for subsequent cytokine analysis.
Stimulation of OT-II CD4+ T Cells In Vitro
Lymph node cells and red blood cell-lysed splenocytes from
OT-II mice were pooled and 2 × 105 cells seeded per well of
a 96-well round bottom plate (Greiner). OVA 323-339 peptide
(OVAp, Charité Berlin) was added at 1 or 0.1 µM. For each
condition six technical repeats were set up. On day three,
culture supernatant was harvested and frozen at –70◦C. Cells
were stained for CD4 and CD25 expression and absolute cell
numbers were determined by FACS using counting beads. To
generate Th1 cells pooled spleen/lymph node cells from an OT-
II mouse were depleted of CD4+ CD25+ regulatory T cells
using anti-CD25 biotin (5 µg/ml, BD) and Streptavidin-beads
and passage over an LD column (both Miltenyi). CD25-depleted
spleen/lymph node cells were then seeded at 1 × 106 cells/well
(48-well plate, Greiner, final volume: 1 ml, 3 × 106 cells in
total), OVAp was added at 1 µM, recombinant mouse IL-12
(R&D Systems, Minneapolis, MN, USA) at 10 ng/ml and goat-
anti-mouse IL-4 (R&D Systems) at 10 µg/ml. To obtain ‘Th0’
cells the CD25-depleted spleen/lymph node cells were stimulated
with OVAp only. After five days of culture, CD4+ T cells were
magnetically purified (CD4+ Isolation kit, Affymetrix, according
to manufacturer’s instructions) and cultured for another two days
in the presence 0.1 µM Proleukin R© (Novartis) (48-well plate,
5 × 105 cells/well). Afterward, the cells were harvested and co-
cultured with T cell-depleted splenocytes (anti-CD90.2 beads,
LD column, Miltenyi) isolated from a WT C57BL/6 mouse (96-
well round-bottom plate; 1 x 105 T cell-depleted splenocytes
per well, 1 × 104 Th1 cells per well, triplicates). OVAp and
Pra1 were added to these cultures in different concentrations.
Every day 15 µl of culture supernatant were harvested per well
to determine cytokine concentrations. On day three the Th1
cells were restimulated with phorbol myristate acetate (5 ng/ml)
and ionomycin (500 ng/ml) for two hours at 37◦C/5% CO2
(v/v) before addition of Brefeldin A (10 µg/ml; all Sigma) and
incubation for another two hours followed by cell surface staining
for CD4, fixation, and permeabiliziation of the cells (Fix/Perm
and Perm buffers, ebioscience) and intracellular staining for
IFNγ expression (anti-IFNγ Alexa Fluor 488, clone XMG1.2,
Biolegend).
Cytokine Detection in Culture
Supernatants
Concentrations of the indicated cytokines were determined
in culture supernatants using LEGENGplexTM (Biolegend)
according to the manufacturer’s instructions.
Statistics
Summary graphs were generated and statistical testing was done
using Excel © 14.4.1 (Microsoft) and Prism 4.0c © (GraphPad).
P < 0.05 was considered statistically significant.
Ethics Statement
Stadt Würzburg (City of Würzburg) and UK Home Office (PPL
30/3038) approved breeding of the mice used in this study and
the animals were culled by Annex IV approved techniques in
accordance with Directive 2010/63/EU.
RESULTS
Pra1 Directly Binds to Mouse CD4+ T
Cells in a Zinc-Dependent Manner
As Pra1 expression of C. albicans is induced upon contact
with human cells and as it has already been shown to strongly
modulate innate immunity (Zipfel et al., 2011), we studied direct
binding of Pra1 to mouse CD4+ T cells in vitro. We used
recombinantly expressed Pra1 purified from Pichia pastoris for
staining and found that Pra1 bound to all splenocytes in a
dose-dependent manner (Figure 1A, left histogram). Among
total splenocytes CD11b+ CD3− monocytic cells bound Pra1
particularly well (Figure 1A, middle left histogram), which was
expected as complement receptor 3 (CR3, Mac1, CD11b/CD18)
had been identified as a cellular receptor for Pra1 on mouse
leukocytes (Soloviev et al., 2007, 2011). Splenic B (Figure 1A,
middle right histogram) and T cells (Figure 1A, right), i.e., CD4+
and CD8+ T cells (Figure 1B), also clearly bound Pra1, albeit to
a lesser extent than the monocytic cells.
As Pra1 binds zinc (Citiulo et al., 2012) we tested whether
zinc influences Pra1 binding to mouse CD4+ T cells. Zn2+ which
is found in serum at a concentration of 10 µM (Feske et al.,
2012) and beyond increased Pra1 binding to mouse CD4+ T
cells (Figures 2A–C) with plateau levels of binding reached after
30 min of incubation (Figure 2D). Moreover, a pra1 deletion
mutant encoding a Pra1 protein lacking the putative zinc-binding
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FIGURE 1 | Candida albicans Pra1 binds to monocytes, B and T cells. (A) Total mouse splenocytes were incubated with Pra1 in the absence of exogenously
added zinc. Pra1 binding was detected indirectly as described in Section “Materials and Methods”. Pra1 bound to all splenocytes (left histogram), CD11b+ CD3−
monocytes (middle left histogram), B220high CD3− B cells (middle right histogram) and T cells (right histogram) dose-dependently. (B) Total mouse lymph node cells
were gated for CD4+ and CD8+ T cells as depicted and Pra1 binding to these subpopulations determined (in the absence of exogenously added zinc). (A,B) One of
at least two experiments with similar result is shown.
domain (Pra11238–299) (Citiulo et al., 2012) showed almost no
binding to mouse CD4+ T cells (Figure 2E).
The zinc binding capacity of Pra1 is shared by its homolog
in A. fumigatus, i.e., the Aspf2 protein (Citiulo et al., 2012). We,
therefore, used recombinantly expressed (P. pastoris) and purified
Aspf2 and tested whether Aspf2 also directly binds to mouse
CD4+ T cells. Aspf2, in contrast to Pra1, however, did not bind
to the mouse T cells even when ZnCl2 was added to the buffer
(Figure 3). Thus, Pra1, but not Aspf2, directly binds to mouse
CD4+ T cells and Pra1 binding is enhanced in the presence of
extracellular zinc.
Complement Regulatory Proteins
Expressed by Mouse CD4+ T Cells Do
Not Interact with Pra1
So far, only complement receptor 3 (CR3, Mac1, CD11b/CD18)
has been identified as a cellular receptor for Pra1 on mouse
leukocytes (Soloviev et al., 2007, 2011). As the staining pattern of
Pra1 showed that Pra1 binds similarly well to all mouse CD4+ T
cells (Figure 1B) we hypothesized that a complement regulatory
protein expressed by all mouse T cells might be the receptor for
Pra1. Therefore, we analyzed Pra1 binding to CD4+ T cells of
CD55−/− mice in more detail as CD55, Crry, and CD59a are
the three complement-regulatory proteins expressed by mouse T
cells (Miwa and Song, 2001). While CD4+ T cells of CD55−/−
mice were clearly devoid of CD55 expression at the cell surface
(Figure 4A) binding of Pra1 was not reduced in the absence
of CD55 (Figure 4B). Moreover, addition of zinc also increased
binding of Pra1 to mouse CD4+ T cells of CD55−/− mice
(Figure 4B). Apart from CD55−/− mice we also studied binding
of Pra1 to CD4+ T cells of Crry−/− and CD59a−/− mice, which
was also not reduced (Figure 4C). Therefore, Pra1 does not seem
to interact with any of the three complement regulatory proteins
expressed on the surface of mouse CD4+ T cells.
Pra1 Binding Co-stimulates Mouse CD4+
T Cells
To gain further insight into the functional consequences of Pra1
binding to CD4+ T cells, we first studied its impact on T cell
activation and proliferation in vitro. To avoid confounding effects
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FIGURE 2 | Binding of C. albicans Pra1 to mouse CD4+ T cells is enhanced by extracellular zinc. (A) Representative histograms depicting Pra1
binding to gated mouse CD4+ T cells (total lymph node cells) in the presence of different concentrations of ZnCl2 (black: Pra1; gray: background staining control).
(B) Summary graph depicting Pra1 (black) versus background staining (gray) of CD4+ T cells in the presence of different concentrations of ZnCl2 (n = 6, two-sided
t-test, ∗p < 0.05). (C) Summary graph showing enhanced binding of Pra1 to mouse CD4+ T cells in the presence of ZnCl2 (relative
MFI(Pra1) = MFI(Pra1)/MFI(background); means ± SD; n = 6; two-sided t-test, ∗p < 0.05). (D) Pra1 on-kinetics at 37◦C. Lymph node cells were incubated with Pra1
for the indicated periods of time before we detected binding of Pra1 to CD4+ T cells (means ± SD of n = 3 separate experiments; two-sided t-test). (E) Comparison
of Pra1wt (white columns) and a mutated Pra1 lacking the zinc-binding domain (aa 238–299, black columns) binding to gated CD4+ T cells in the presence of
10 µM ZnCl2 (left) or 0 and 100 µM ZnCl2 (right). Means + SD (n = 3–6 individual measurements). Two-sided t-test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
through the interaction of Pra1 with CD11b/CD18 expressed by
monocytic cells in our cultures, we FACS-sorted mouse CD4+
T cells which lack CD11b/CD18 to more than 99% purity.
Stimulation of these highly pure CD4+ T cells by plate-bound
anti-CD3 mAb and titrated amounts of Pra1 led to a dose-
dependent increase in proliferation and CD25 expression similar
to what we observed by adding an anti-CD28 mAb (Dennehy
et al., 2006) (Figures 5A,B). Moreover, Pra1 truly induced a
co-stimulatory signal in the T cells as in the absence of CD3
stimulation Pra1 did not activate the cells (Figure 5C). The same
effect was observed for the anti-CD28 mAb (Figure 5C). Binding
of Pra1 to mouse CD4+ T cells, thus, enhanced T cell activation
and proliferation, which comprise the first steps of the adaptive
immune response.
Cytokine Secretion by In Vivo Generated
Mouse CD4+ Memory T Cells is Inhibited
in the Presence of Pra1
While the activation of naïve T cells and clonal expansion
mark the beginning of the CD4+ T cell response, secretion
of cytokines such as IFNγ characterize its effector and
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FIGURE 3 | The Pra1 homolog of A. fumigatus, Aspf2, does not bind to
mouse CD4+ T cells. Representative staining of Aspf2 on gated CD4+ T
cells derived from the spleen as performed before with Pra1. Aspf2- and
Pra1-staining on cells from the same mouse with Pra1- and Aspf2- (black)
and background staining (gray). The bar diagram shows relative MFI of the
Aspf2-signal with and without ZnCl2 (relative
MFI(Aspf2) = MFI(Aspf2)/MFI(background); means ± SD; n = 3).
memory phase. We, therefore, analyzed cytokines in the
supernatants of purified CD4+ T cells, containing in vivo
generated memory T cells, stimulated via plate-bound anti-CD3
mAb and soluble Pra1 or anti-CD28 mAb (Dennehy et al.,
2006) (Figure 6A). In contrast to its co-stimulatory effect on
T cell activation and proliferation Pra1 suppressed secretion
of both Th1 and Th2 cytokines (Figure 6A). Only IL-17
secretion appeared not to be affected, while secretion of IL-10
was below the detection limit in these experiments. Seemingly
at odds with our observation concerning expression of the
IL-2 receptor α-chain, CD25 (Figure 5), IL-2 concentrations
were also reduced in the presence of Pra1. We assume that
this reflects increased IL-2 consumption through increased
receptor expression rather than reduced IL-2 production
(Malek, 2008) uniting these two findings. To further test
the capacity of Pra1 to inhibit cytokine secretion we added
Pra1 to purified CD4+ T cells which we co-stimulated with
anti-CD3/anti-CD28 mAb-coated Dynabeads R© (Figure 6B).
Even under these conditions, which more faithfully mimic
T cell-antigen presenting cell interactions than stimulation
via plate-bound antibodies, Pra1 reduced cytokine, i.e.,
IFNγ, secretion by the CD4+ T cells (Figure 6B). The
same was true for the supernatant of cultured C. albicans
containing the whole array of secreted fungal proteins
(Figure 6B).
Apart from binding to CD4+ T cells, Pra1 interacts with
CD11b/CD18 integrin (Mac1) expressed by monocytic and
granulocytic cells (Soloviev et al., 2011). To test whether Pra1 also
suppresses IFNγ secretion in the presence of Mac1-expressing
antigen-presenting cells (APCs) we stimulated total splenocytes
from T cell receptor-transgenic OT-II mice with 1 µM OVA-
peptide 323–339 in the presence of 100 or 1 ng/ml Pra1
(Figure 6C). Also under these conditions Pra1 inhibited IFNγ
secretion by the OT-II CD4+ T cells.
Both in the presence of recombinant Pra1 as well as C. albicans
supernatant, secretion of cytokines by mouse CD4+ T cells was,
thus, reduced.
Depending on the Strength of the TCR
Signal Pra1 Also Reduces Secretion of
IFNγ by In Vitro Generated Th1 Cells
T cells isolated from healthy mice producing effector cytokines
are by definition mostly resting memory T cells. During
acute invasive C. albicans infection or C. albicans-induced
inflammation the fungus, however, mainly encounters effector
T cells. Therefore, we first deliberately generated OT-II Th1
effector cells during a five-day culture in vitro followed by a
two-day resting phase and subsequent re-stimulation of the
Th1 cells in the presence of APCs and different concentrations
of peptide antigen and Pra1 (Figure 7A). Addition of Pra1
to Th1 cells stimulated with 0.1 µM OVA peptide reduced
IFNγ secretion into the supernatant (Figure 7A, middle), while
this was not the case at 1 µM OVA peptide (Figure 7A,
right). Analyzing intracellular IFNγ expression by the Th1 cells
after PMA/ionomycin re-stimulation, further, showed that the
reduced secretion of IFNγ into the culture supernatant in the
presence of Pra1 was not due to a per se lower capacity of
the Th1 cells to produce IFNγ. Without OVAp re-stimulation
the expression of IFNγ by the Th1 cells was, however, reduced
suggesting that Pra1 increases the threshold for stimulation-
induced cytokine secretion by CD4+ T cells. Incubation of
Th1 cells with Pra1 showed, in comparison to OT-II CD4+ T
cells cultured under Th0 conditions in parallel, that Th1 cells
bind Pra1 better than Th0 cells (Figures 7C,D) suggesting that
differentiated effector memory Th1 cells are a primary target of
Pra1. In autoreactive pathogenic T cells Kv1.3 has been shown
to be the main voltage-gated potassium channel and blocking the
channel with the ShK peptide inhibits the autoreactive pathogenic
T cells in animal models of autoimmunity in vivo (Beeton et al.,
2001) and in cell cultures of human T cells in vitro (Wulff et al.,
2003). Using a fluorescently labeled ShK peptide we observed that
the Th1 cells expressed more Kv1.3 channels than Th0 cells and
that Pra1 binding and Kv1.3 expression were positively correlated
in Th1 cells (Figure 7E). Pra1, thus, preferentially bound to
effector/memory Th1 cells inhibiting IFNγ secretion provided
TCR stimulation did not surpass a certain threshold.
DISCUSSION
In this study, we describe the direct interaction of the secreted
C. albicans protein Pra1 with mouse CD4+ T cells. Binding
of Pra1 to the CD4+ T cells was enhanced by extracellular
Zn2+. Moreover, Pra1 binding inhibited cytokine secretion from
CD4+ T cells in vitro thus constituting a novel immune evasion
mechanism for C. albicans.
In line with its known capacity to scavenge Zn2+ ions (Citiulo
et al., 2012) Pra1 bound more efficiently to mouse CD4+ T cells
in the presence of extracellular zinc than in its absence (Figure 1).
This activity was in contrast to what we observed for Aspf2, the
zinc-binding Pra1-homolog of A. fumigatus (Citiulo et al., 2012).
Aspf2 did not bind to mouse CD4+ T cells – either in the presence
or absence of Zn2+ (Figure 3). As both proteins carry a HIS-
tag, which, of course, by itself is capable of binding Zn2+ (Evers
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FIGURE 4 | Comparison of Pra1 binding to CD4+ T cells of wild-type and CD55−/− mice. (A) CD55 staining of lymphocytes from WT (black) and CD55−/−
mice (gray). As a staining control, WT lymphocytes were incubated without the anti-CD55 primary mAb (dashed dark gray). (B) Binding of Pra1 to lymph node CD4+
T cells from WT and CD55−/− mice. Gray: Staining control without primary mAb. Left bar diagram show relative MFI of Pra1 signal in WT and CD55−/− cells
(relative MFI(Pra1) = MFI(Pra1)/MFI(background); means ± SD; n = 3; two-sided t-test). Right diagram depicts MFI of Pra1 staining of CD55−/− CD4+ T cells in the
presence of different concentrations of ZnCl2 (mean, upper and lower quartile, field of values, n = 3). (C) Comparison of Pra1 binding to splenic CD4+ T cells of WT,
Crry−/− and CD59a−/− mice (n = 3-8 mice/group; means ± SD; two-sided t-test; ∗p < 0.05).
et al., 2008), the enhanced binding of Pra1 to mouse CD4+ T
cells after addition of ZnCl2 was not merely mediated by the
HIS-tag. Moreover, even under conditions where we did not add
ZnCl2 during the staining procedure we detected a positive signal
for Pra1 binding (Figures 1, 2). This data implies that the Pra1
binding to the surface of the CD4+ T cells is not strictly zinc-
dependent and/or that free zinc present in preparations of lymph
node cells and splenocytes might be sufficient to allow for Pra1
binding.
The molecular basis for the enhanced Pra1 binding mediated
by ZnCl2 is so far not clear. We envisage that Zn2+ binding might
induce a conformational change in Pra1 as has been described
for many other Zn2+-binding proteins (Ebert and Altman, 2008).
Such a structural change has, however, not yet been described for
Pra1.
While the receptor for Pra1 on the surface of mouse CD4+
T cells is still elusive, CR3 (CD11b/CD18, Mac-1) expressed by
neutrophils and monocytic cells has been shown to bind Pra1
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FIGURE 5 | Pra1 co-stimulates mouse CD4+ T cells. (A) CFSE dilution and CD25 expression by mouse CD4+ T cells after a 3 day culture in the presence or
absence of plate-bound αCD3 mAb and Pra1 (1 ng/ml) or αCD28 mAb (1 µg/ml) added in solution. (B) Summary graph depicting a dose-dependent increase in
co-stimulation in the presence of plate-bound αCD3 mAb and Pra1 (0% = frequency CFSElow CD25+ with αCD3 mAb only; 100% = frequency CFSElow CD25+ with
αCD3 + 10 µg/ml αCD28 mAb). (C) Direct stimulatory activity of Pra1 in the absence of plate-bound αCD3 (0% = frequency CFSElow CD25+ medium only;
100% = frequency CFSElow CD25+ with plate-bound αCD3 mAb). (B,C): Means ± SD (n = 3 individual experiments). Two-sided t-test: ∗p < 0.05.
and that this binding is important to protect mice after systemic
C. albicans infection (Soloviev et al., 2011). On mouse CD4+ T
cells it is, however, not a complement regulatory protein that
interacts with Pra1 (Figure 4). Therefore, it is unlikely that
modulation of complement activation, which has been shown
to crucially contribute to T cell stimulation and differentiation
(Arbore and Kemper, 2016), accounts for the effects of Pra1 on
mouse CD4+ T cells. Analysis of Kv1.3 expression in parallel
to Pra1 binding to in vitro polarized CD4+ Th1 cells, however,
showed that cells with the highest capacity to bind Pra1 also
expressed high levels of Kv1.3 (Figure 7). While we do not, yet,
know whether Kv1.3 is a receptor for Pra1 it may not be the
only molecule Pra1 interacts with on the T cell surface. Kv1.3
expression cannot be detected on resting T cells by FACS using
the ShK-F6CA peptide (Beeton et al., 2003), while Pra1 binding
to resting T cells is detectable by flow cytometry as detailed in
this study. Functionally, Pra1 might interfere with K+ currents
through Kv1.3 by direct binding to the channel or by binding
in the vicinity of Kv1.3 and ‘delivering’ Zn2+ ions. Extracellular
Zn2+ binds to Kv1.3 inhibiting the transport of K+ ions through
the channel (Teisseyre and Mozrzymas, 2002, 2006).
Apart from directly interacting with CD4+ T cells, Pra1
could also modulate T cell responses by binding to APCs via
interaction with CD11b/CD18 (Soloviev et al., 2011) or via the
still unknown Pra1 receptor also expressed on T cells. Therefore,
it was important to study the effects on cytokine secretion by
CD4+ T cells in the presence of APCs. Irrespective of whether
APCs were present in our assays Pra1 inhibited cytokine secretion
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FIGURE 6 | Modulation of cytokine secretion by Pra1 upon polyclonal and antigen-specific CD4+ T cell stimulation. (A) The left panel shows the absolute
amount of cytokines secreted by purified WT CD4+ T cells after three days of stimulation with plated-bound anti-CD3-mAb (2.5 µg/ml) either alone or together with
Pra1 or anti-CD28 mAb (clone E18, 10 µg/ml) added in solution. The right column shows the amounts of secreted cytokines normalized to the ‘anti-CD3 mAb only’
cultures (=100%; first bar in the left panel). Means + SD of n = 5 individual experiments are shown. (B) IFNγ secretion upon stimulation of purified CD4+ T cells with
anti-CD3/anti-CD28 mAb-coated Dynabeads R©. Pra1 was added at 1 ng/ml and the C. albicans supernatant was diluted 1:25. Means + SD of triplicate cultures are
shown. The experiment was repeated with similar result. (C) Lymph node cells from OT-II mice were stimulated with 1 µM OVAp in the absence or presence of Pra1
as indicated before supernatants were harvested on day three and IFNγ concentrations determined (means ± SD of triplicate cultures; experiment was repeated
with similar result). (A–C) Two-sided t-test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
by the CD4+ T cells (Figures 6, 7) suggesting that the direct
interaction of Pra1 with the CD4+ T cells was also the crucial
event in the cultures containing APCs.
Recombinant Pra1 and supernatant of C. albicans cultures
inhibited IFNγ release from CD4+ T cells (Figure 6). While
we do not know to what extent Pra1 contributes to the overall
inhibitory effect of the C. albicans supernatant this observation
highlights that C. albicans, through its secretome, modulates
CD4+ T cell responses. Further experimentation is required to
delineate whether Pra1 is the only C. albicans protein mediating
these effects or, more likely, whether other secreted fungal
proteins also contribute to effector T cell inhibition.
Apart from Th1 cells, Th17 cells also crucially contribute
to anti-fungal immunity either through direct effects or by
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FIGURE 7 | IFNγ secretion by OT-II Th1 cells in the presence of Pra1. (A) In vitro generated OT-II Th1 cells were re-stimulated in the presence of the indicated
amounts of OVAp, Pra1 and APCs. Culture supernatants were harvested on days one to three and IFNγ content determined. Means ± SD of triplicate cultures are
shown. The experiment was repeated with similar result. An ANOVA was used to compare cultures with to those without Pra1. (B) At the end of the re-stimulation
cultures, we determined IFNγ expression by OT-II Th1 cells intracellularly. Means ± SD of three independent experiments are shown. A two-sided t-test was used to
compare groups. (C) Representative Pra1 staining (black; gray: control without Pra1) of OT-II CD4+ T cells stimulated with OVAp under Th0 (left; 1% IFNγ+) or Th1
conditions for 5 days (right, 53% IFNγ+). (E) Detection of Kv1.3 expression via staining in parallel to Pra1 binding in the samples shown in (C,D). (D,E): Means ± SD
of triplicate analyses. The experiment was repeated twice with similar result. A two-sided t-test was used to compare groups. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
supporting Th1 versus Th2 cell differentiation (Romani, 2011;
Zelante et al., 2016). In contrast to other cytokines, IL-17 release
from CD4+ T cells was not reduced in the presence of Pra1
(Figure 6). This might have to do with the degree of TCR
signal strength required to induce optimal cytokine release from
different CD4+ T helper cell subpopulations. For Th1 cells we
observed that strong TCR stimulation overcame Pra1-induced
suppression of cytokine release (Figure 7). As maximal IL-17
release, in contrast to IFNγ release, has been reported to require
low TCR stimulation (Purvis et al., 2010) further experimentation
is required to determine whether, indeed, Pra1 differentially
regulates cytokine release from Th1 and Th17 cells.
In summary, our data identify Pra1 as an inhibitor of
mouse CD4+ effector T cell function in vitro, thus, mediating
evasion of C. albicans from potentially harmful CD4+ T cell
responses. While subversion of the CD4+ T cell response during
commensalism might be of mutual benefit for C. albicans and the
host, during invasive infection/sepsis blocking protective CD4+
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T cell immunity might worsen clinical outcome. Therefore, the
findings of our study suggest that therapeutic targeting of soluble
Pra1 might enhance CD4+ T cell responses protecting the host
from invasive C. albicans infections.
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